Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells

Biochemical and Biophysical Research Communications

Volumn 373, Issue 4, 2008, Pages 643-647

  Liu, Xiaohong ^a   Zhang, Shuhui ^a   Lin, Jing ^a   Zhang, Shunmin ^a   Feitelson, Mark A ^b   Gao, Hengjun ^c   Zhu, Minghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Temple University   (United States)

^c NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

Author keywords

Cell cycle; Hepatitis B virus x; Hepatocellular carcinoma; Mutation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HEPATITIS B VIRUS X PROTEIN; MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P53;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GENE REPRESSION; GENETIC TRANSFECTION; HBX GENE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS GENE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; PLASMIDS; PROTO-ONCOGENE PROTEINS C-MDM2; SEQUENCE DELETION; TRANS-ACTIVATORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

HEPATITIS B VIRUS;

EID: 48949115075     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.087     Document Type: Article

References (32)

1. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 6 (2006) 674-687
2. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31 (2002) 339-346
3. Liu X.H., Wang L., Zhang S.H., Lin J., Zhang S.M., Feitelson M.A., Gao H.J., and Zhu M.H. Mutations in the carboxyl terminus of the X protein of Hepatitis B Virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis (2008) 10.1093/carcin/bgn111
4. Ng R.K., Lau C.Y., Lee S.M., Tsui S.K., Fung K.P., and Waye M.M. cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem. Biophys. Res. Commun. 322 (2004) 827-835
5. Kim C.M., Koike K., Saito I., Miyamura T., and Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 (1991) 317-320
6. Yu D.Y., Moon H.B., Son J.K., Jeong S., Yu S.L., Yoon H., Han Y.M., Lee C.S., Park J.S., Lee C.H., Hyun B.H., Murakami S., and Lee K.K. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J. Hepatol. 31 (1999) 123-132
7. Schaefer S., Seifer M., Grimmsmann T., Fink L., Wenderhold S., Hohne M.W., and Gerlich W.H. Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein. J. Gen. Virol. 79 Pt. 4 (1998) 767-777
8. Tarn C., Bilodeau M.L., Hullinger R.L., and Andrisani O.M. Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines. J. Biol. Chem. 274 (1999) 2327-2336
9. Gottlob K., Pagano S., Levrero M., and Graessmann A. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Res. 58 (1998) 3566-3570
10. Sirma H., Giannini C., Poussin K., Paterlini P., Kremsdorf D., and Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18 (1999) 4848-4859
11. Wu B.K., Li C.C., Chen H.J., Chang J.L., Jeng K.S., Chou C.K., Hsu M.T., and Tsai T.F. Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem. Biophys. Res. Commun. 340 (2006) 916-928
12. Ahn J.Y., Chung E.Y., Kwun H.J., and Jang K.L. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway. Gene 275 (2001) 163-168
13. Terradillos O., Pollicino T., Lecoeur H., Tripodi M., Gougeon M.L., Tiollais P., and Buendia M.A. p53-Independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17 (1998) 2115-2123
14. Qiao L., Leach K., McKinstry R., Gilfor D., Yacoub A., Park J.S., Grant S., Hylemon P.B., Fisher P.B., and Dent P. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology 34 (2001) 906-917
15. Miyazawa J., Mitoro A., Kawashiri S., Chada K.K., and Imai K. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res. 64 (2004) 2024-2029
16. Liang X., Liu Y., Zhang Q., Gao L., Han L., Ma C., Zhang L., Chen Y.H., and Sun W. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J. Immunol. 178 (2007) 503-510
17. Liu X.H., Lin J., Zhang S.H., Zhang S.M., Feitelson M.A., Gao H.J., and Zhu M.H. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J. Gastroenterol. 14 (2008) 1346-1352
18. Iavarone M., Trabut J.B., Delpuech O., Carnot F., Colombo M., Kremsdorf D., Brechot C., and Thiers V. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J. Hepatol. 39 (2003) 253-261
19. Tan T.L., and Chen W.N. A proteomics analysis of cellular proteins associated with HBV genotype-specific HBX: potential in identification of early diagnostic markers for HCC. J. Clin. Virol. 33 (2005) 293-298
20. Tu H., Bonura C., Giannini C., Mouly H., Soussan P., Kew M., Paterlini-Brechot P., Brechot C., and Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 61 (2001) 7803-7810
21. Hung L., and Kumar V. Antisense regulation of expression and transactivation functions of the tumorigenic HBx and c-myc genes. Biochem. Biophys. Res. Commun. 344 (2006) 293-299
22. Merzianu M., Jiang L., Lin P., Wang X., Weber D.M., Vadhan-Raj S., Nguyen M.H., Medeiros L.J., and Bueso-Ramos C.E. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and does not correlate with p65 NF-kappaB activation. Mod. Pathol. 19 (2006) 891-898
23. Wang X., Jin D.Y., Wong H.L., Feng H., Wong Y.C., and Tsao S.W. MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells. Oncogene 22 (2003) 109-116
24. Lazze M.C., Savio M., Pizzala R., Cazzalini O., Perucca P., Scovassi A.I., Stivala L.A., and Bianchi L. Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines. Carcinogenesis 25 (2004) 1427-1433
25. Ou D.P., Tao Y.M., Tang F.Q., and Yang L.Y. The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. Int. J. Cancer 120 (2007) 1208-1214
26. Acosta R., Montanez C., Fuentes-Mera L., Gonzalez E., Gomez P., Quintero-Mora L., Mornet D., Alvarez-Salas L.M., and Cisneros B. Dystrophin Dp71 is required for neurite outgrowth in PC12 cells. Exp. Cell Res. 296 (2004) 265-275
27. Feitelson M.A., and Clayton M.M. X antigen polypeptides in the sera of hepatitis B virus-infected patients. Virology 177 (1990) 367-371
28. Elmore L.W., Hancock A.R., Chang S.F., Wang X.W., Chang S., Callahan C.P., Geller D.A., Will H., and Harris C.C. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl. Acad. Sci. USA 94 (1997) 14707-14712
29. Feitelson M.A., and Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett. 252 (2007) 157-170
30. Kwun H.J., and Jang K.L. Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res. 32 (2004) 2202-2213
31. Kim J.H., Sohn S.Y., Benedict Yen T.S., and Ahn B.Y. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein. Biochem. Biophys. Res. Commun. 366 (2008) 1036-1042
32. Chin R., Earnest-Silveira L., Koeberlein B., Franz S., Zentgraf H., Dong X., Gowans E., Bock C.T., and Torresi J. Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis. J. Hepatol. 47 (2007) 325-337